NM_001282116.2:c.2092G>C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001282116.2(RFX3):c.2092G>C(p.Glu698Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001282116.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFX3 | ENST00000617270.5 | c.2092G>C | p.Glu698Gln | missense_variant | Exon 17 of 17 | 2 | NM_001282116.2 | ENSP00000482598.1 | ||
RFX3 | ENST00000382004.7 | c.2092G>C | p.Glu698Gln | missense_variant | Exon 18 of 18 | 1 | ENSP00000371434.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2092G>C (p.E698Q) alteration is located in exon 18 (coding exon 16) of the RFX3 gene. This alteration results from a G to C substitution at nucleotide position 2092, causing the glutamic acid (E) at amino acid position 698 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.